BTIG Starts AnaptysBio (ANAB) at Buy, ‘Novel Therapies in Large Markets Make a Compelling Case for Upside’

Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/BTIG+Starts+AnaptysBio+%28ANAB%29+at+Buy%2C+%27Novel+Therapies+in+Large+Markets+Make+a+Compelling+Case+for+Upside%27/22829318.html for the full story.